Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Assets (2016 - 2025)

Historic Assets for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to $13.7 million.

  • Pharma-Bio Serv's Assets fell 1619.9% to $13.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $13.7 million, marking a year-over-year decrease of 1619.9%. This contributed to the annual value of $13.7 million for FY2025, which is 1619.9% down from last year.
  • Pharma-Bio Serv's Assets amounted to $13.7 million in Q4 2025, which was down 1619.9% from $13.6 million recorded in Q3 2025.
  • In the past 5 years, Pharma-Bio Serv's Assets ranged from a high of $30.2 million in Q1 2021 and a low of $13.6 million during Q3 2025
  • Over the past 5 years, Pharma-Bio Serv's median Assets value was $20.0 million (recorded in 2022), while the average stood at $20.1 million.
  • As far as peak fluctuations go, Pharma-Bio Serv's Assets soared by 1543.86% in 2021, and later crashed by 2890.68% in 2022.
  • Quarter analysis of 5 years shows Pharma-Bio Serv's Assets stood at $23.9 million in 2021, then dropped by 13.67% to $20.7 million in 2022, then fell by 3.63% to $19.9 million in 2023, then decreased by 18.14% to $16.3 million in 2024, then fell by 16.2% to $13.7 million in 2025.
  • Its Assets stands at $13.7 million for Q4 2025, versus $13.6 million for Q3 2025 and $13.9 million for Q2 2025.